{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T22:33:21Z","timestamp":1781735601610,"version":"3.54.5"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.vaccine.2024.126687","type":"journal-article","created":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T03:59:31Z","timestamp":1736567971000},"page":"126687","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["A systematic review and meta-analysis of adverse events following measles-containing vaccines in infants less than 12 months of age"],"prefix":"10.1016","volume":"47","author":[{"given":"Dorthe Maria","family":"Vittrup","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salma","family":"Charabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lone Graff","family":"Stensballe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.126687_bb0005","author":"WHO"},{"key":"10.1016\/j.vaccine.2024.126687_bb0025","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/infdis\/jit143","article-title":"Waning of maternal antibodies against measles, mumps, rubella, and varicella in communities with contrasting vaccination coverage","volume":"208","author":"Waaijenborg","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126687_bb0030","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.15585\/mmwr.mm7246a3","article-title":"Progress toward measles elimination - worldwide, 2000-2022","volume":"72","author":"Minta","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2024.126687_bb0035","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1177\/1460458208096654","article-title":"A content analysis of mass media sources in relation to the MMR vaccine scare","volume":"14","author":"Guillaume","year":"2008","journal-title":"Health Informatics J"},{"key":"10.1016\/j.vaccine.2024.126687_bb0040","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/nri1228","article-title":"Misleading media reporting?","volume":"3","author":"Lewis","year":"2003","journal-title":"The MMR story Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2024.126687_bb0050","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S1473-3099(19)30395-0","article-title":"Immunogenicity, effectiveness, and safety of measles vaccination in infants younger than 9 months: a systematic review and meta-analysis","volume":"19","author":"Nic Lochlainn","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126687_bb0060","first-page":"366","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","author":"Sterne","year":"2019","journal-title":"The BMJ"},{"key":"10.1016\/j.vaccine.2024.126687_bb0065","first-page":"4","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ (Online)"},{"key":"10.1016\/j.vaccine.2024.126687_bb0070","series-title":"The Immunological Basis of Immunization Series Module 7: Measles","volume":"62","author":"Moss","year":"2009"},{"key":"10.1016\/j.vaccine.2024.126687_bb0075","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1093\/infdis\/jiv756","article-title":"Tolerability of early measles-mumps-rubella vaccination in infants aged 6-14 months during a measles outbreak in the Netherlands in 2013-2014","volume":"213","author":"Van Der Maas","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126687_bb0080","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1086\/592756","article-title":"Evaluation of the immune response to a 2-dose measles vaccination schedule administered at 6 and 9 months of age to HIV-infected and HIV-uninfected children in Malawi","volume":"198","author":"Helfand","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126687_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102421","article-title":"Immunogenicity and reactogenicity following MMR vaccination in 5\u20137-month-old infants: a double-blind placebo-controlled randomized clinical trial in 6540 Danish infants","volume":"68","author":"Vittrup","year":"2024","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.vaccine.2024.126687_bb0090","first-page":"199","article-title":"High immunogenicity of measles AIK-C vaccine produced in Vietnam","volume":"16","author":"Hien","year":"2011","journal-title":"Eastern Journal of Medicine"},{"key":"10.1016\/j.vaccine.2024.126687_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjopen-2014-007202","article-title":"Immunogenicity and safety of early vaccination with two doses of a combined measles-mumps-rubellavaricella vaccine in healthy Indian children from 9 months of age: a phase III, randomised, non-inferiority trial","volume":"5","author":"Lalwani","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.vaccine.2024.126687_bb0100","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s15010-007-6337-z","article-title":"Safety and immunogenicity of early vaccination with two doses of tetravalent measles-mumps-rubella-varicella (MMRV) vaccine in healthy children from 9 months of age","volume":"35","author":"Goh","year":"2007","journal-title":"Infection"},{"key":"10.1016\/j.vaccine.2024.126687_bb0105","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1016\/j.vaccine.2012.02.062","article-title":"Immunogenicity and safety of a two-dose regimen of a combined measles, mumps, rubella and varicella live vaccine (ProQuad\u00ae) in infants from 9 months of age","volume":"30","author":"Vesikari","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126687_bb0110","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1016\/j.vaccine.2014.04.044","article-title":"Similar immunogenicity of measles-mumps-rubella (MMR) vaccine administrated at 8 months versus 12 months age in children","volume":"32","author":"He","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126687_bb0115","first-page":"100074","article-title":"Immunogenicity and safety of concurrent or sequential administration of live, attenuated SA 14-14-2 Japanese encephalitis vaccine (CD-JEV) and measles-mumps-rubella vaccine in infants 9\u201312 months of age in the Philippines: a non-inferiority phase 4 random","volume":"6","author":"Capeding","year":"2020","journal-title":"Vaccine: X"},{"key":"10.1016\/j.vaccine.2024.126687_bb0120","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1016\/j.vaccine.2008.02.042","article-title":"Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants","volume":"26","author":"Gatchalian","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126687_bb0125","first-page":"1188","article-title":"Effect of an early dose of measles vaccine on morbidity between 18 weeks and 9 months of age: a randomized, controlled trial in Guinea-Bissau","volume":"215","author":"Do","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126687_bb0130","first-page":"353","article-title":"Comparison of AIK-C measles vaccine in infants at 6 months with Schwarz vaccine at 9 months: a randomized controlled trial in Ghana","volume":"76","author":"Nkrumah","year":"1998","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2024.126687_bb0135","doi-asserted-by":"crossref","first-page":"2150030","DOI":"10.1080\/21645515.2022.2150030","article-title":"Safety, immunogenicity and non-interference of concomitant typhoid vi capsular polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV\u00ae) and measles or measles-mumps-rubella vaccines in 8\u20139 months-old Indian children","volume":"18","author":"Vadrevu","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2024.126687_bb0140","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1016\/S0264-410X(00)00096-7","article-title":"Comparison of immunogenicity and reactogenicity of a measles, mumps and rubella (MMR) vaccine in German children vaccinated at 9-11, 12-14 or 15-17 months of age","volume":"18","author":"Klinge","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126687_bb0145","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/0264-410X(95)93314-Y","article-title":"Comparison of Edmonston-Zagreb, Connaught and Schwarz measles vaccines in Cameroonian infants aged 3-8 months","volume":"13","author":"Ndumbe","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126687_bb0150","first-page":"343","volume":"12","author":"Tsai","year":"1999","journal-title":"Immunogenicity and Safety of Standard-Titer AIK-C"},{"key":"10.1016\/j.vaccine.2024.126687_bb0155","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S1473-3099(18)30650-9","article-title":"Immunogenicity and safety of measles-rubella vaccine co-administered with attenuated Japanese encephalitis SA 14\u201314\u20132 vaccine in infants aged 8 months in China: a non-inferiority randomised controlled trial","volume":"19","author":"Li","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126687_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.conctc.2023.101232","article-title":"A phase II\/III randomised, comparative study evaluating the safety and immunogenicity of biological E\u2019s live, attenuated measles-rubella vaccine in 9\u201312 month old healthy infants","volume":"36","author":"Thuluva","year":"2023","journal-title":"Contemporary Clinical Trials Communications"},{"key":"10.1016\/j.vaccine.2024.126687_bb0165","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1016\/j.vaccine.2019.04.025","article-title":"Immunogenicity of the AIK-C measles vaccine in infants aged <9\u00a0months in Vietnam","volume":"37","author":"Hong","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126687_bb0170","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00006454-199004000-00008","article-title":"Measles, mumps and rubella immunization at nine months in a developing country","volume":"9","author":"Schoub","year":"1990","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2024.126687_bb0175","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1016\/j.vaccine.2022.06.027","article-title":"Immunogenicity and safety of the inactivated enterovirus 71 vaccine administered concomitantly with the measles-rubella vaccine in infants aged 8 months in China: a noninferiority randomized controlled trial","volume":"40","author":"Zhao","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126687_bb0180","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3390\/children10010104","article-title":"Safety of vaccination within first year of life\u2014the experience of one general medicine center","volume":"10","author":"Pop","year":"2023","journal-title":"Children"},{"key":"10.1016\/j.vaccine.2024.126687_bb0185","doi-asserted-by":"crossref","first-page":"e321","DOI":"10.1542\/peds.2014-1822","article-title":"Safety of measles-containing vaccines in 1-year-old children","volume":"135","author":"Klein","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2024.126687_bb0190","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1001\/jamapediatrics.2013.2745","article-title":"Effect of age on the risk of fever and seizures following immunization with measles-containing vaccines in children","volume":"167","author":"Rowhani-Rahbar","year":"2013","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.vaccine.2024.126687_bb0195","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41541-019-0132-6","article-title":"The how\u2019s and what\u2019s of vaccine reactogenicity","volume":"4","author":"Herv\u00e9","year":"2019","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2024.126687_bb0200","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"10.1016\/j.vaccine.2024.126687_bb0205","doi-asserted-by":"crossref","DOI":"10.1097\/INF.0000000000001201","article-title":"Adverse events after MMR or MMRV vaccine in infants under nine months old","volume":"35","author":"Woo","year":"2016","journal-title":"Pediatr Infect Dis J"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24013690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24013690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T03:15:12Z","timestamp":1739416512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24013690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":36,"alternative-id":["S0264410X24013690"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126687","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review and meta-analysis of adverse events following measles-containing vaccines in infants less than 12 months of age","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126687","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126687"}}